Coverage
-
April 29, 2016
Pfizer Inc. on Friday lost a bid to limit a 26-year-old ban on comparing its Advil products to McNeil-PPC Inc.'s Tylenol when a New York federal judge found that even pediatric versions of Advil that didn't exist at the initial order are still covered by it.
1 other articles on this case.
View all »